Your browser doesn't support javascript.
loading
Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients.
Li, Bing; Ren, Ge; Guo, Wei; Zhang, Jiang; Lam, Sai-Kit; Zheng, Xiaoli; Teng, Xinzhi; Wang, Yunhan; Yang, Yang; Dan, Qinfu; Meng, Lingguang; Ma, Zongrui; Cheng, Chen; Tao, Hongyan; Lei, Hongchang; Cai, Jing; Ge, Hong.
Afiliación
  • Li B; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Ren G; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Guo W; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Zhang J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Lam SK; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Zheng X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Teng X; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Wang Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Yang Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Dan Q; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Meng L; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Ma Z; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Cheng C; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Tao H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Lei H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Cai J; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.
  • Ge H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Front Pharmacol ; 13: 971849, 2022.
Article en En | MEDLINE | ID: mdl-36199694
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza